Tube leukocyte adherence-inhibition response to syngeneic mammary tumor antigens and alloantigens from Ehrlich ascites carcinoma and fibrosarcoma was studied in spontaneous mammary tumor-bearing C3H/Jax mice. The mice with limited tumor burden responded significantly to the mammary tumor antigen and the Ehrlich ascites carcinoma antigen. The reactivity disappeared with increased tumor load. Oscillatory responses in leukocyte adherence inhibition to the reactive antigens was observed with increasing tumor weight. There was no response to the alloantigen of fibrosarcoma.
Get full access to this article
View all access options for this article.
References
1.
ArthurL.O., BauerR.F., OrmeL.S., FineD.L.: Coexistence of the mouse mammary tumor virus (MMTV) major glycoprotein and natural antibodies to MMTV in sera of mammary tumor-bearing mice.Virology, 87: 266–275, 1978.
2.
BlairP.B., LaneM.A.: Age-and tumor-correlated changes in functional antibody responses to MTV in neonatally infected mice.Int. J. Cancer, 25: 273–279, 1980.
3.
CreemersP., BentvelzenP.: Cellular immunity to the mammary tumor virus in mice bearing primary mammary tumors.Eur. J. Cancer, 13: 503–510, 1977.
4.
DunhamL.J., StewartH.L.: A survey of transplantable and transmissible animal tumors.J. Natl. Cancer Inst., 13: 1299–1377, 1953.
5.
GilletteR.W., LoweryL.T.: Virus-dependent cytostatic activity to mammary tumor cells of lymphocytes from normal mice.Cancer Res., 36: 4008–4014, 1976.
6.
GrosserN., ThomsonD.M.P.: Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.Cancer Res., 35: 2571–2579, 1975.
7.
HallidayW.J., MillerS.: Leukocytes adherence inhibition: A simple test for cell-mediated tumor immunity and serum blocking factors.Int. J. Cancer, 9: 477–483, 1972.
8.
HellströmI., HellströmK.E., ShantzG.: Demonstration of tumor-associated immunity with leukocyte adherence inhibition (LAI) assay.Int. J. Cancer, 18: 354–361, 1976.
HoltP.C., RobertsL.M., FimmelP.J., KeastD.: The LAI microtest: A rapid and sensitive procedure for the demonstration of cell-mediated immunity in vitro.J. Immunol. Methods, 8: 277–288, 1975.
11.
IhleJ.N., ArthurL.O., FineD.L.: Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.Cancer Res., 36: 2840–2844, 1976.
12.
KoppiT.A., HallidayW.J.: Further characterization of the cells involved in leukocyte adherence inhibition with murine tumor extracts.Cell. Immunol., 66: 394–406, 1982.
13.
KoppiT.A., HallidayW.J., McKenzieI.F.C.: Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumors.II. Nature of blocking and unblocking factors in serum. J. Natl. Cancer Inst., 66: 1097–1102, 1981.
14.
KotlarH.K., SannerT.: Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.J. Natl. Cancer Inst., 66: 265–271, 1981.
15.
LowryO.H., RosenbroughN.J., FarrA.L., RandallR.J.: Protein measurement with the polyphenol reagent.J. Biol. Chem., 193: 265–275, 1951.
16.
MartiJ.H., GrosserN., ThomsonD.M.P.: Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity.II. Monocyte reacts with tumor antigens via cytophilic antitumor antibody. Int. J. Cancer., 18: 48–57, 1976.
17.
MortensenR.F., ElsonL.M.: Leukocyte adherence inhibition response to murine sarcoma virus-induced tumors.1. Cell requirements, specificity, lack of H-2 restriction and role of antibody. J. Immunol., 124: 2361–2323, 1980.
18.
MüllerM., HagemanP.C., DaamsJ.H.: Spontaneous occurrence of precipitating antibodies to the mammary tumor virus in mice.J. Natl. Cancer Inst., 47: 801–805, 1971.
19.
RussoA.J., HowellJ.H., LevesonS.H., HolyokeE.D., GoldrosenM.H.: Micro-leukocyte adherence inhibition: Cellular basis of the mechanism of reactivity.J. Immunol., 121: 1914–1919, 1978.
20.
SabaT.M., AntikatzidesT.G.: Humoral-mediated macrophage response during tumor growth.Br. J. Cancer, 32: 471–482, 1975.
21.
ThomsonD.M.P.: Soluble tumor-specific antigen and its relationship to tumor growth.Int. J. Cancer, 15: 1016–1029, 1975.
ThomsonD.M.P., TatarynD.N., SchwartzR., Mc FarlanesJ.K.: Abrogation of the phenomenon of leukocyte adherence inhibition by excess circulating tumor antigen.Eur. J. Cancer, 15: 1095–1106, 1979.
